miR-375 |
Induces ferroptosis in gastric cancer |
Downregulates SLC7A11 |
[34] |
miR-4715-3p |
Induces ferroptosis in gastric and esophageal carcinomas |
Downregulates AURKA and GPX4 expression |
[170] |
miR-214-3p |
Induces ferroptosis in HCC |
Downregulates ATF4 and SLC7A11 |
[35] |
miR-101-3p |
Induces ferroptosis in lung cancer |
Downregulates TBLR1, NF-κB, GPX4 and PTGS2 expression |
[26] |
miR-324-3p |
Induces ferroptosis in LUAD |
Downregulates GPX4 |
[27] |
miR-324-3p |
Induces ferroptosis in breast cancer |
Downregulates GPX4 |
[28] |
miR-5096 |
Induces ferroptosis in breast cancer |
Downregulates SLC7A11 |
[36] |
miR-1287-5p |
Induces ferroptosis in osteosarcoma |
Downregulates GPX4 |
[171] |
miR-137 |
Inhibits ferroptosis in melanoma |
Downregulates SLC1A5 |
[93] |
miR-9 |
Inhibits ferroptosis in melanoma |
Downregulates GOT1, inhibits glutaminolysis |
[172] |
miR-130b-3p |
Inhibits ferroptosis in melanoma |
Downregulates DKK1, upregulates NRF2 and HO-1 expression |
[173] |
miR-103a-3p |
Inhibits ferroptosis in gastric cancer |
Downregulates GLS2, prevents hydrolysis of glutamine to glutamate |
[174] |
miR-522 |
Inhibits ferroptosis in gastric cancer |
Downregulates ALOX15 |
[60] |
miR-23a-3p |
Inhibits ferroptosis in HCC |
Downregulates ACSL4 |
[54] |
miR-4443 |
Inhibits ferroptosis in NSCLC |
Downregulates m6A, upregulates FSP1 |
[46] |
miR-424-5p |
Inhibits ferroptosis in ovarian cancer |
Downregulates ACSL4 |
[55] |
miR-7-5p |
Inhibits ferroptosis in ovarian, oral squamous cell and HCC |
Downregulates mitoferrin, reduces mitochondrial iron levels |
[99] |
miR-7-5p |
Inhibits ferroptosis in cervical and oral squamous carcinomas |
Upregulates ferritin, downregulates ALOX12 expression |
[59] |